Our work in mice demonstrates that the CLL-dependent induction of Cxcl13 in stromal cells is, at least in part, retinoid-dependent, since treatment with the RA antagonist BMS493 prevents Cxcl13 induction. Here, CXCL13 is linked to B-cell chronic lymphocytic leukemia.